» Articles » PMID: 2392569

Hippocampal Formation: Anatomy and the Patterns of Pathology in Alzheimer's Disease

Overview
Journal Prog Brain Res
Publisher Elsevier
Specialty Neurology
Date 1990 Jan 1
PMID 2392569
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Anatomical studies of the primate brain have shown that the subicular and CA1 allocortices give rise to hippocampal efferents that course to numerous telencephalic and diencephalic targets including other parts of the cortex. The hippocampal formation is damaged heavily in Alzheimer's disease, and is a focal point for pathology. We examined the anteroposterior extent of the hippocampal formation in 52 cases of Alzheimer's disease, 6 cases of other types of dementia and 10 age-compatible controls, to determine the patterns of pathology. We have observed that only certain subfields of the hippocampal formation are affected by cell loss, neurofibrillary tangles and neuritic plaques, while adjacent, anatomically distinct subfields are relatively spared. The portions of the hippocampal formation most crucial for both cortical and subcortical efferent projections are severely affected by Alzheimer pathological changes. Most notable are neurofibrillary tangles in the subicular and CA1 subfields. Layer IV of entorhinal cortex, specifically affected by neurofibrillary tangles. Hippocampal input is also compromised. For example, layer II of entorhinal cortex, which gives rise to perforant pathway hippocampal afferents, also undergoes severe neurofibrillary changes. Neuritic plaques appear in a distinct layer in the terminal zone of the perforant pathway, which carries the majority of corticohippocampal afferents. Plaques are also common in a zone that receives serotoninergic projections from the raphe complex, thus compromising another hippocampal afferent. In sum, these changes disrupt intrinsic and extrinsic hippocampal circuitry at multiple levels, and the pathological dissection deprives the hippocampal formation of many of its efferent and afferent connections with cortical and subcortical structures important in memory-related neural systems. These changes likely contribute to the memory impairment that characterizes Alzheimer's disease and the devastating intellectual decline that ensues.

Citing Articles

Shape-based disease grading via functional maps and graph convolutional networks with application to Alzheimer's disease.

Mayer J, Baum D, Ambellan F, von Tycowicz C BMC Med Imaging. 2024; 24(1):342.

PMID: 39696064 PMC: 11657580. DOI: 10.1186/s12880-024-01513-z.


Differential Vulnerability of Hippocampal Subfields to Amyloid and Tau Deposition in the Lewy Body Diseases.

Ye R, Goodheart A, Locascio J, Peterec E, Properzi M, Thibault E Neurology. 2024; 102(12):e209460.

PMID: 38815233 PMC: 11244748. DOI: 10.1212/WNL.0000000000209460.


Dementia risk and thalamic nuclei volumetry in healthy midlife adults: the PREVENT Dementia study.

Shah S, Dounavi M, Malhotra P, Lawlor B, Naci L, Koychev I Brain Commun. 2024; 6(2):fcae046.

PMID: 38444908 PMC: 10914447. DOI: 10.1093/braincomms/fcae046.


Neuroprotective Effects of N-methyl-(2S, 4R)-trans-4-hydroxy-L-proline (NMP) against Amyloid-β-Induced Alzheimer's Disease Mouse Model.

Ali J, Khan A, Park J, Tahir M, Ahmad W, Choe K Nutrients. 2023; 15(23).

PMID: 38068844 PMC: 10708322. DOI: 10.3390/nu15234986.


Predicting cognitive dysfunction and regional hubs using Braak staging amyloid-beta biomarkers and machine learning.

Bhattarai P, Taha A, Soni B, Thakuri D, Ritter E, Chand G Brain Inform. 2023; 10(1):33.

PMID: 38043122 PMC: 10694120. DOI: 10.1186/s40708-023-00213-8.